# Advisor Review - Advisor 1/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-29T22:19:16.100739
**Response ID:** resp_0367a06afb2ed0b200697bcd98d5fc81909fb71c40bb24018e
**Tokens:** 41180 in / 10877 out
**Response SHA256:** 6e242daa1151d040

---

I checked the draft only for **fatal errors** in (1) data–design alignment, (2) regression sanity, (3) completeness, and (4) internal consistency. I did **not** evaluate writing, novelty, or minor modeling choices.

## 1) Data–Design Alignment (critical)
- **Treatment timing vs. outcome data coverage:** Treatment “full-exposure years” run **2013–2021** (Table 2) and LAUS outcomes cover **2007–2023** (Section 3.1). So **max(treatment year) ≤ max(data year)** holds.  
- **Post-treatment observations by cohort:** Latest cohort (2021) has **2021–2023** post-treatment observations (3 years), earliest (2013) has through **2023** (11 years). This matches cohort windows described and the event-time support in Tables 6–8 (e=+10 only for 2013 cohort).  
- **Treatment definition consistency:** The “full-exposure year” convention is used consistently in the narrative and in Table 2, and the anticipation window of 1 year is explicitly tied to the March-outcome timing.

No data–design misalignment detected.

## 2) Regression Sanity (critical)
I scanned the reported coefficients/SEs across the main and appendix tables shown (Tables 3–13, 15, 17–20):
- No implausibly huge coefficients (e.g., >10 in logs or >100 in levels).
- No pathological SEs (e.g., SEs orders of magnitude larger than estimates suggesting collinearity explosions).
- No impossible entries (NaN/Inf/NA), negative SEs, or invalid statistics.

No regression-output sanity violations detected.

## 3) Completeness (critical)
- Main regression table reports **N, FE structure, SE description** (Table 3).
- Additional key analyses described in the text are actually shown somewhere in the provided tables/figures (event studies, Bacon decomposition, placebo, pre-COVID restriction, first stage).
- No placeholders (“TBD”, “XXX”, empty cells) found in the displayed materials.
- Some appendix-style tables don’t have N in the body (e.g., Table 15), but the **notes explicitly report N and sample composition**, which satisfies “sample size reported” for completeness.

No completeness failures detected.

## 4) Internal Consistency (critical)
- The headline estimates in the abstract match Table 3 (e.g., log employment ATT **0.0036 (0.0079)**; unemployment rate ATT **−0.242 (0.293)** under not-yet-treated).
- Cohort counts and cohort-years are consistent across Table 2, the cohort-count narrative, and Table 4.
- Pre-COVID sample sizes are arithmetically consistent (Table 18: 50×13=650; Table 19 row: 46×13=598).

No internal numerical contradictions detected.

ADVISOR VERDICT: PASS